JSON
Kataria R, Shoaie S, Grigoriadis A, Wan JCM
Trends Cancer 9 (11) 879-882 [2023-11-00; online 2023-09-01]
Microbial cell-free DNA (microbial cfDNA) offers a minimally invasive approach for profiling the microbiome. Despite technical and biological challenges, the potential of microbial cfDNA for cancer detection is increasingly being evaluated using deep sequencing, novel laboratory approaches, and computational methods. Targeting the microbiome using liquid biopsies could improve early cancer detection.
PubMed 37659908
DOI 10.1016/j.trecan.2023.08.001
Crossref 10.1016/j.trecan.2023.08.001
pmc: PMC10873208
pii: S2405-8033(23)00157-7